Follow-The-Filings

Security · featured owners

SPRY Ars Pharmaceuticals Inc.

COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 0.3%
  • $9M
  • 1 add 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Nathan Fischel - Dafna Ca...) · not free-float ownership

  1. Nathan Fischel add 0.25%
  2. Dan Loeb 0.17%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Dan Loeb - Third Point 2026 Q2 0.17% Hold 1,000,000 $8M history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.25% Add +17.9% 164,285 $1M history
Ron Baron - Bamco Inc. (Baron Capital) exited 2026 Q2 last 2026 Q1 0.03% Exit −0.03 pp 1,273,341 $10M history

2 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 25 shown

Filed Form Detail Links
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 24, 2026 · 9 forms Filing Doc
4 Period Jun 12, 2026 · 2 forms Filing Doc
4 Period Jan 2, 2026 · 7 forms Filing Doc
4 Period Nov 12, 2025 · 2 forms Filing Doc
4 Period Nov 13, 2025 Filing Doc
4 Period Aug 21, 2025 · 2 forms Filing Doc
4 Period Aug 19, 2025 Filing Doc

Updated 7 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $30,000 $89.15M $84.28M
Net income -$54.36M $8M -$171.3M
Net margin * -181216.7% 9.0% -203.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $231.73M $334.3M $284.9M
Total non-current assets * $1.46M $16.86M $42.76M
Total assets $233.19M $351.15M $327.65M
Total current liabilities $2.39M $23.44M $39.14M
Total non-current liabilities * $37,000 $70.92M $174.25M
Total equity $230.76M $256.8M $114.26M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$59.27M $13.55M -$170.87M
Cash from investing -$87.18M -$106.1M $56.77M
Cash from financing $6.9M $72.4M $104.6M
Net change in cash -$139.55M -$20.15M -$9.5M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders